The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy

2002 ◽  
Vol 39 (1) ◽  
pp. 1-6 ◽  
Author(s):  
T. Forst ◽  
T. Pohlmann ◽  
T. Kunt ◽  
K. Goitom ◽  
G. Schulz ◽  
...  
2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Alise Kalteniece ◽  
Maryam Ferdousi ◽  
Shazli Azmi ◽  
Womba M. Mubita ◽  
Andrew Marshall ◽  
...  

2021 ◽  
Vol 28 (5) ◽  
pp. 1745-1751
Author(s):  
Maryam Ferdousi ◽  
Shazli Azmi ◽  
Alise Kalteniece ◽  
Ioannis Nikolaos Petropoulos ◽  
Georgios Ponirakis ◽  
...  

Diagnostics ◽  
2021 ◽  
Vol 11 (2) ◽  
pp. 165
Author(s):  
Jamie Burgess ◽  
Bernhard Frank ◽  
Andrew Marshall ◽  
Rashaad S. Khalil ◽  
Georgios Ponirakis ◽  
...  

Diabetic peripheral neuropathy (DPN) is the most common complication of both type 1 and 2 diabetes. As a result, neuropathic pain, diabetic foot ulcers and lower-limb amputations impact drastically on quality of life, contributing to the individual, societal, financial and healthcare burden of diabetes. DPN is diagnosed at a late, often pre-ulcerative stage due to a lack of early systematic screening and the endorsement of monofilament testing which identifies advanced neuropathy only. Compared to the success of the diabetic eye and kidney screening programmes there is clearly an unmet need for an objective reliable biomarker for the detection of early DPN. This article critically appraises research and clinical methods for the diagnosis or screening of early DPN. In brief, functional measures are subjective and are difficult to implement due to technical complexity. Moreover, skin biopsy is invasive, expensive and lacks diagnostic laboratory capacity. Indeed, point-of-care nerve conduction tests are convenient and easy to implement however questions are raised regarding their suitability for use in screening due to the lack of small nerve fibre evaluation. Corneal confocal microscopy (CCM) is a rapid, non-invasive, and reproducible technique to quantify small nerve fibre damage and repair which can be conducted alongside retinopathy screening. CCM identifies early sub-clinical DPN, predicts the development and allows staging of DPN severity. Automated quantification of CCM with AI has enabled enhanced unbiased quantification of small nerve fibres and potentially early diagnosis of DPN. Improved screening tools will prevent and reduce the burden of foot ulceration and amputations with the primary aim of reducing the prevalence of this common microvascular complication.


2021 ◽  
Vol 45 (3) ◽  
pp. 631-638
Author(s):  
Shazli Azmi ◽  
Maryam Ferdousi ◽  
Yifen Liu ◽  
Safwaan Adam ◽  
Zohaib Iqbal ◽  
...  

2015 ◽  
pp. 95-103 ◽  
Author(s):  
Linda van der Tol ◽  
Camiel Verhamme ◽  
Ivo N. van Schaik ◽  
Anneke J. van der Kooi ◽  
Carla E. M. Hollak ◽  
...  

2019 ◽  
Vol 24 (2) ◽  
pp. 448-456 ◽  
Author(s):  
Dominique C. F. Van Assche ◽  
Leon Plaghki ◽  
Etienne Masquelier ◽  
Samar M. Hatem

1996 ◽  
Vol 99 (4) ◽  
pp. 382
Author(s):  
J. Reulen ◽  
A. v/d Zwan ◽  
F. Spaans ◽  
M. van Kleef ◽  
M. Hartmann

2017 ◽  
Vol 41 (5) ◽  
pp. S62
Author(s):  
Leif E. Lovblom ◽  
Vera Bril ◽  
Andrej Orszag ◽  
Katie Edwards ◽  
Nicola Pritchard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document